Drug – bio-affecting and body treating compositions – Preparations characterized by special physical form – Particulate form
Patent
1996-09-30
1999-12-07
Page, Thurman K.
Drug, bio-affecting and body treating compositions
Preparations characterized by special physical form
Particulate form
424 95, 424426, A61K 914
Patent
active
059979046
ABSTRACT:
In accordance with the present invention, there are provided stabilized total nutrient admixture (TNA) compositions which are useful for the in vivo parenteral delivery of pharmacologically acceptable lipids or fats, as well as methods for the preparation thereof. In particular, the pharmacologically acceptable lipid or fat is contained within a protein walled shell. In a particular embodiment of the invention, a TNA composition using human serum albumin (HSA) as a stabilizer has been prepared as a convenient three-in-one formulation (i.e., containing a fat emulsion, dextrose, and amino acids plus electrolytes). This "three-in-one" formulation can be prepared in liquid form or in dry form (comprising submicron-sized nanoparticles). The dried material is stable, even under long term storage, and is easily reconstituted immediately before use by simply adding sterile water (with or without vitamin supplementation). This serves to rehydrate the powder into a TNA suitable for injection. The long shelf life, ease of reconstitution, and single-component injectability of invention compositions provide significant cost savings, as such compositions can be reconstituted and administered safely, even in the home. In addition, HSA, the stabilizing agent of choice for use in the practice of the present invention, has been shown to improve survival and wellness when given as a supplement to patients receiving conventional forms of total nutrient admixtures.
REFERENCES:
patent: 3959457 (1976-05-01), Speaker et al.
patent: 4073943 (1978-02-01), Wretlind et al.
patent: 4247406 (1981-01-01), Widder et al.
patent: 4572203 (1986-02-01), Feinstein
patent: 4671954 (1987-06-01), Goldberg et al.
patent: 4718433 (1988-01-01), Feinstein
patent: 4789550 (1988-12-01), Hommel et al.
patent: 4844882 (1989-07-01), Widder et al.
patent: 5110606 (1992-05-01), Geyer et al.
patent: 5362478 (1994-11-01), Desai et al.
patent: 5439686 (1995-08-01), Desai et al.
patent: 5498421 (1996-03-01), Grinstaff et al.
patent: 5505932 (1996-04-01), Grinstaff et al.
patent: 5508021 (1996-04-01), Grinstaff et al.
patent: 5512268 (1996-04-01), Grinstaff et al.
patent: 5560933 (1996-10-01), Soon-Shing et al.
Burgess et al., "Potential use of albumin microspheres as a drug delivery system. I. Preparation and in vitro release of steroids," International Journal of Pharmaceutics, 39: 129-136 (1987).
Chen et al., "Comparison of albumin and casein micropheres as a carrier for doxorubicin," J. Pharm. Pharmacol., 39:978-985 (1987).
Feinstein et al., "Two-Dimensional Contrast Echocardiography. I. In Vitro Development and Quantitative Analysis of Echo Contrast Agents," JACC, 3(1):14-20 (1984).
Grinstaff & Suslick, "Nonaqueous Liquid Filled Microcapsules," Polym. Prepr., 32:255-256 (1991).
Gupta et al., "Albumin microspheres. III. Synthesis and characterization of micropheres containing adriamycin and magnetite," International Jouranal of Pharmaceutics, 43:167-177 (1988).
Ishizaka et al., "Preparation of Egg Albumin Microcapsules and Microspheres," Journal of Pharmaceutical Sciences, 70(4):358-363 (1981).
Klibanov et al., "Amphipathic polyethyleneglycols effectively prolong the circulation time of liposomes," FEBS, 268(1):235-237 (1990).
Koenig & Meltzer, "Effect of Viscosity on the Size of Microbubbles Generated for Use as Echocardiographic Contrast Agents," Journal of Cardiovascular ultrasonography, 5(1):3-4 (1986).
Leucuta et al., "Albumin microspheres as a drug delivery system for epirubicin: pharmaceutical, pharmacokinetic and biological aspects," International Journal of Pharmaceutics, 41:213-217 (1988).
Molecular Biosystems, Inc., "Albunex.TM.--Preclinical Investigator's Package".
Moseley et al., "Microbubbles: A Novel MR Susceptibility Contrast Agent," 10th Annual Meeting of Society of Magnetic Resonance in Medicine (1991).
Suslick & Grinstaff, "Protein Microencapsulation of Nonaqueous Liquids," J. Am. Chem. Soc., 112(21):7807-7809 (1990).
Willmott & Harrison, "Characterisation of freeze-dried albumin microspheres containing the anti-cancer drug adriamycin," International Journal of Pharmaceutics, 43:161-166 (1988).
. . ,"Serum Albumin Beads: An Injectable, Biodegradable System for the Sustained Release of Drugs," Science, 213(10):233-235 (1981).
Brown et al., "Effect of albumin supplementation during parenteral nutrition on hospital morbidity" Critical Care Medicine, 16:1177-1182 (1988).
Magdassi et al., "Chemical Instability of Phosholipids: A Key Factor in Stabilization of Perfluorocarbon Emulsions" J. Disp. Sci. Tech., 12 (1) : 69-82 (1991).
Desai Neil P.
Magdassi Shlomo
Soon-Shiong Patrick
Tao Chunlin
Yang Andrew
American Bioscience, Inc.
Benston, Jr. William E.
Page Thurman K.
Reiter Stephen E.
LandOfFree
Total nutrient admixtures as stable multicomponent liquids or dr does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Total nutrient admixtures as stable multicomponent liquids or dr, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Total nutrient admixtures as stable multicomponent liquids or dr will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-820868